Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,456	1,502	888	1,340	2,126	1,536
Market Cap Growth	38.80%	69.05%	-33.71%	-36.96%	38.35%	35.75%
Enterprise Value	1,571	2,396	1,820	2,114	2,768	2,202
Last Close Price	1.26	1.30	0.77	1.16	1.84	1.33
PE Ratio	66.78	33.67	-	-	33.01	-
Forward PE	15.75	52.00	-	21.09	-	-
PS Ratio	1.09	1.14	0.70	0.83	1.86	2.68
PB Ratio	1.53	1.86	1.10	1.44	2.21	1.44
P/TBV Ratio	1.70	2.09	1.37	1.77	2.73	1.73
P/FCF Ratio	10.88	7.46	12.43	-	1180.90	-
P/OCF Ratio	8.83	6.13	9.49	69.43	46.01	-
EV/Sales Ratio	1.18	1.83	1.43	1.31	2.42	3.84
EV/EBITDA Ratio	8.02	14.33	24.30	31.78	21.54	-
EV/EBIT Ratio	19.45	31.95	-	-	66.70	-
EV/FCF Ratio	11.74	11.90	25.46	-	1537.84	-
Debt / Equity Ratio	0.62	1.20	1.38	0.95	0.85	0.57
Debt / EBITDA Ratio	3.01	4.62	9.48	8.57	5.60	-
Debt / FCF Ratio	4.40	4.82	15.53	-	455.06	-
Asset Turnover	0.59	0.54	0.53	0.67	0.48	0.24
Inventory Turnover	1.49	1.48	1.28	1.60	1.60	1.32
Quick Ratio	2.13	1.14	1.13	1.17	1.18	0.76
Current Ratio	3.08	2.19	2.26	2.44	2.32	1.17
Return on Equity (ROE)	2.61%	1.86%	-9.11%	-3.83%	4.08%	-27.90%
Return on Assets (ROA)	2.23%	1.92%	-0.63%	-0.74%	1.09%	-5.44%
Return on Capital (ROIC)	2.95%	2.54%	-0.82%	-0.99%	1.50%	-7.51%
Return on Capital Employed (ROCE)	5.40%	4.90%	-	-	2.30%	-
Earnings Yield	12.61%	2.97%	-11.15%	-2.19%	3.03%	-19.08%
FCF Yield	9.19%	13.40%	8.05%	-3.31%	0.08%	-12.00%
Buyback Yield / Dilution	-	-	-	-	-9.21%	-61.46%
Total Shareholder Return	-	-	-	-	-9.21%	-61.46%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.